Metadata Search
AbbVie Deutschland
Page 1 of 32 results
Sort by: relevance publication year Download as CSV

Contrasting the Influence of Cationic Amino Acids on the Viscosity and Stability of a Highly Concentrated Monoclonal Antibody

Journal Article published 11 Nov 2016 in Pharmaceutical Research volume 34 issue 1 on pages 193 to 207

Research funded by AbbVie Deutschland

Authors: Barton J. Dear, Jessica J. Hung, Thomas M. Truskett, Keith P. Johnston

Randomized Controlled Study to Evaluate the Efficacy of Adalimumab in Patients with Different Forms of Refractory Uveitis

Journal Article published 29 Dec 2017 in Ocular Immunology and Inflammation on pages 1 to 8

Research funded by AbbVie Deutschland (unknown)

Authors: Friederike Mackensen, Carsten Heinz, Eva Jakob, Viviane Grewing, Hanns-Martin Lorenz, Arnd Heiligenhaus, Regina Max, Matthias D. Becker

Limit cycles bifurcating from the periodic annulus of the weight-homogeneous polynomial centers of weight-degree 2

Journal Article published Feb 2016 in Applied Mathematics and Computation volume 274 on pages 47 to 54

Research funded by AbbVie Deutschland (MTM2008-03437, 2014SGR-568, 88881.030454/2013-01)

Authors: J. Llibre, B.D. Lopes, J.R. de Moraes

Tregalizumab – A Monoclonal Antibody to Target Regulatory T Cells

Journal Article published 25 Jan 2016 in Frontiers in Immunology volume 7

Research funded by AbbVie Deutschland

Authors: Martin König, Faiza Rharbaoui, Silke Aigner, Benjamin Dälken, Jörg Schüttrumpf

Nonmotor fluctuations: phenotypes, pathophysiology, management, and open issues

Journal Article published 12 Jul 2017 in Journal of Neural Transmission volume 124 issue 8 on pages 1029 to 1036

Research funded by AbbVie Deutschland

Authors: Joseph Classen, Jiri Koschel, Christian Oehlwein, Klaus Seppi, Peter Urban, Christian Winkler, Ullrich Wüllner, Alexander Storch

Long-Term Physical Stability of PVP- and PVPVA-Amorphous Solid Dispersions

Journal Article published 7 Dec 2016 in Molecular Pharmaceutics volume 14 issue 1 on pages 157 to 171

Research funded by AbbVie Deutschland

Authors: Kristin Lehmkemper, Samuel O. Kyeremateng, Oliver Heinzerling, Matthias Degenhardt, Gabriele Sadowski

Matrix meets inflammation and DNA repair: Meeting report of the third ADF Round Table

Journal Article published 27 Apr 2017 in Experimental Dermatology volume 26 issue 5 on pages 464 to 466

Research funded by AbbVie Deutschland

Authors: Johanna M. Brandner, Steffen Emmert, Kerstin Wolk, Ralf J. Ludwig

A reduced 12-joint ultrasound examination predicts lack of X-ray progression better than clinical remission criteria in patients with rheumatoid arthritis

Journal Article published 7 Apr 2017 in Rheumatology International volume 37 issue 8 on pages 1347 to 1356

Research funded by AbbVie Deutschland

Authors: Eugenio de Miguel, The ECO-DAI Group, Angela Pecondón-Español, Manuel Castaño-Sánchez, Alfonso Corrales, Ricardo Gutierrez-Polo, Manuel Rodriguez-Gomez, Jose A. Pinto-Tasende, Jose L. Rivas, José Ivorra-Cortés

Prognostic factors for change in self-reported anxiety and depression in spondyloarthritis patients: data from the population-based SpAScania cohort from southern Sweden

Journal Article published 16 Aug 2017 in Scandinavian Journal of Rheumatology volume 47 issue 3 on pages 185 to 193

Research funded by AbbVie Deutschland | Faculty of Medicine at Lund University | Norrbacka-Eugenia Foundation, Sweden | Region Skåne | Pfizer Foundation

Authors: JJL Meesters, S Bergman, E Haglund, LTH Jacobsson, IF Petersson, A Bremander

Palivizumab use in infants with Down syndrome—report from the German Synagis™ Registry 2009–2016

Journal Article published 12 Apr 2018 in European Journal of Pediatrics volume 177 issue 6 on pages 903 to 911

Research funded by AbbVie Deutschland (German Synagis Registry)

Authors: Arne Simon, Susanne Gehrmann, Gudrun Wagenpfeil, Stefan Wagenpfeil

Influence of Low-Molecular-Weight Excipients on the Phase Behavior of PVPVA64 Amorphous Solid Dispersions

Journal Article published Jan 2018 in Pharmaceutical Research volume 35 issue 1

Research funded by AbbVie Deutschland

Authors: Kristin Lehmkemper, Samuel O. Kyeremateng, Matthias Degenhardt, Gabriele Sadowski

Viscosity Reduction of a Concentrated Monoclonal Antibody with Arginine·HCl and Arginine·Glutamate

Journal Article published 21 Oct 2016 in Industrial & Engineering Chemistry Research volume 55 issue 43 on pages 11225 to 11234

Research funded by Welch Foundation (F-1319, F-1696) | AbbVie Deutschland | National Science Foundation (1247945)

Authors: Ameya U. Borwankar, Barton J. Dear, April Twu, Jessica J. Hung, Aileen K. Dinin, Brian K. Wilson, Jingyan Yue, Jennifer A. Maynard, Thomas M. Truskett, Keith P. Johnston

Long-term effectiveness of tocilizumab in patients with rheumatoid arthritis, stratified by number of previous treatment failures with biologic agents: results from the German RABBIT cohort

Journal Article published 16 Nov 2017 in Rheumatology International volume 38 issue 4 on pages 579 to 587

Research funded by AbbVie Deutschland | MSD Sharp & Dohme | Bristol-Myers Squibb | Pfizer | Roche | UCB

Authors: Lisa Baganz, Adrian Richter, Jörn Kekow, Arnold Bussmann, Andreas Krause, Carsten Stille, Joachim Listing, Angela Zink, Anja Strangfeld

Safety and efficacy of etanercept and adalimumab in children aged 2 to 4 years with juvenile idiopathic arthritis

Journal Article published 5 Oct 2016 in Clinical Rheumatology volume 35 issue 12 on pages 2925 to 2931

Research funded by Pfizer Germany | Roche Germany | AbbVie Deutschland

Authors: D. Windschall, G. Horneff

Frozen in Time: Kinetically Stabilized Amorphous Solid Dispersions of Nifedipine Stable after a Quarter Century of Storage

Journal Article published 30 Nov 2016 in Molecular Pharmaceutics volume 14 issue 1 on pages 183 to 192

Research funded by AbbVie Deutschland

Authors: Frank Theil, Sankaran Anantharaman, Samuel O. Kyeremateng, Holger van Lishaut, Sebastian H. Dreis-Kühne, Jörg Rosenberg, Markus Mägerlein, Gerd H. Woehrle

Differentiation of atypical Parkinson syndromes

Journal Article published 27 Feb 2017 in Journal of Neural Transmission volume 124 issue 8 on pages 997 to 1004

Research funded by AbbVie Deutschland | Deutsche Forschungsgemeinschaft (HO2402/6-2)

Authors: Günter U. Höglinger, Jan Kassubek, Ilona Csoti, Reinhard Ehret, Heinz Herbst, Ingmar Wellach, Jürgen Winkler, Wolfgang H. Jost

Rates of sustained virological response 12 weeks after the scheduled end of direct-acting antiviral (DAA)-based hepatitis C virus (HCV) therapy from the National German HCV registry: does HIV coinfection impair the response to DAA combination therapy?

Journal Article published 25 Jan 2018 in HIV Medicine volume 19 issue 4 on pages 299 to 307

Research funded by Deutsches Zentrum für Infektionsforschung | AbbVie Deutschland | Bristol-Myers Squibb | Gilead Sciences | Janssen-Cilag GmbH | MSD Sharp & Dohme GmbH | Roche Pharma AG

Authors: J Bischoff, S Mauss, C Cordes, T Lutz, S Scholten, A Moll, H Jäger, M Cornberg, MP Manns, A Baumgarten, JK Rockstroh

Real-world experience with the all-oral, interferon-free regimen of ombitasvir/paritaprevir/ritonavir and dasabuvir for the treatment of chronic hepatitis C virus infection in the German Hepatitis C Registry

Journal Article published 25 May 2017 in Journal of Viral Hepatitis volume 24 issue 10 on pages 840 to 849

Research funded by AbbVie | AbbVie Deutschland | Bristol-Myers Squibb Foundation | Gilead Sciences | Janssen-Cilag GmbH | Merck Sharp and Dohme | Roche

Authors: T. M. Welzel, H. Hinrichsen, C. Sarrazin, P. Buggisch, A. Baumgarten, S. Christensen, T. Berg, S. Mauss, G. Teuber, K. Stein, K. Deterding, F. van Bömmel, R. Heyne, C. John, T. Zimmermann, T. Lutz, E. Schott, J. Hettinger, H. Kleine, B. König, D. Hüppe, H. Wedemeyer

Investigational drugs targeting 5-HT6 receptors for the treatment of Alzheimer’s disease

Journal Article published 7 Nov 2015 in Expert Opinion on Investigational Drugs volume 24 issue 12 on pages 1515 to 1528

Research funded by AbbVie Deutschland (no number)

Authors: Karsten Wicke, Andreas Haupt, Anton Bespalov

A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO registry

Journal Article published 4 May 2017 in Annals of the Rheumatic Diseases volume 76 issue 8 on pages 1426 to 1431

Research funded by AbbVie Deutschland

Authors: Bente Glintborg, Inge Juul Sørensen, Anne Gitte Loft, Hanne Lindegaard, Asta Linauskas, Oliver Hendricks, Inger Marie Jensen Hansen, Dorte Vendelbo Jensen, Natalia Manilo, Jakob Espesen, Mette Klarlund, Jolanta Grydehøj, Sabine Sparre Dieperink, Salome Kristensen, Jimmi Sloth Olsen, Henrik Nordin, Stavros Chrysidis, Dorte Dalsgaard Pedersen, Michael Veedfald Sørensen, Lis Smedegaard Andersen, Kathrine Lederballe Grøn, Niels Steen Krogh, Lars Pedersen, Merete Lund Hetland